Kristina Torfgård
CEO
Replay available
IRLAB Therapeutics AB (publ) (IRLAB_A) Q2 2025 Earnings Call
IRLAB Therapeutics AB (publ) (STO: IRLAB_A) Q2 2025 earnings conference call, held 2025-08-27. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Niklas Waters
Vice President Research and Development
Victor Sievert
CFO
Fredrik Thur
Equity Analyst, Redeye
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Irlab Therapeutics Ab Class A.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.919 Welcome to this live Q2 presentation by research company iLab 00:00:05.919 -- 00:00:10.365 addressing Parkinson and other CNS diseases. 00:00:10.365 -- 00:00:14.491 Presenting today is CEO Kristina Torfgård, 00:00:14.491 -- 00:00:19.498 Vice President Research and Development Niklas Waters and CFO Victor 00:00:19.498 -- 00:00:24.786 Sievert. After the presentation there will be a Q&A with equity analysts 00:00:24.786 -- 00:00:28.010 and viewers can ask their questions in the live chat. 00:00:28.010 -- 00:00:34.058 I hereby welcome CEO Kristina Torfgård and please go ahead with your presentation. 00:00:34.243 -- 00:00:36.989 Thank you very much, Mattias. 00:00:36.989 -- 00:00:38.989 So 00:00:39.193 -- 00:00:44.324 this is our disclaimer and we are listed on Nasdaq Stockholm main market 00:00:44.324 -- 00:00:49.390 to remind about that. Very pleased to have you all listening in today. 00:00:49.390 -- 00:00:51.814 Can I have the first slide there? Thank you. 00:00:51.814 -- 00:00:57.563 Which is the agenda for today. So I will start with some news during the period. 00:00:57.563 -- 00:01:00.288 Hand over to Nicolas, 00:01:00.288 -- 00:01:04.615 EVP, head of R&D, to take you through the R&D update. 00:01:04.615 -- 00:01:09.703 And after that, we will hear Victor Sievers, our CFO, to 00:01:09.703 -- 00:01:14.770 take you through the financials. And then I will come back in there and talk 00:01:14.770 -- 00:01:20.116 and make some concluding words. And this will be then followed by a Q&A 00:01:20.116 -- 00:01:25.261 session, as you already heard. So we have had a very good period also this time. 00:01:25.261 -- 00:01:27.864 We are very excited about 00:01:27.864 -- 00:01:31.168 the progress we are doing with the projects. 00:01:31.168 --...